Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of Anaprazole Sodium and Rifampicin in healthy volunteers
CTR20255109Phase 4Active
- Sponsor
- Xuanzhu Biopharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of anaprazole sodium in duodenal ulcer, erosive esophagitis (EE), sponsored by Xuanzhu Biopharmaceutical. Started Dec 2025; status: active.
02
Drugs
anaprazole sodium
03
Conditions
duodenal ulcererosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20255109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255109.